Review: could Bone cancer metastatic cause Spinal osteoarthritis?
We study 88 people who have Bone cancer metastatic from FDA and social media. Among them, 14 have Spinal osteoarthritis. Find out below who they are, other conditions they have and drugs they take.
Stay connected: join a mobile support group for people who have Bone cancer metastatic and Spinal osteoarthritis >>>
Spinal osteoarthritis (joint cartilage loss in spine) (latest reports from 121,124 patients) has been reported by people with osteoporosis, osteopenia, multiple myeloma, high blood pressure, pain.
On Jul, 31, 2014: 88 people who have bone cancer metastatic are studied. Among them, 14 (15.91%) have Spinal Osteoarthritis. They amount to 0.01% of all the 121,124 people who have Spinal Osteoarthritis on eHealthMe.
Gender of people who have bone cancer metastatic and experienced Spinal osteoarthritis * :
|Spinal osteoarthritis||100.00%||0.00% |
Age of people who have bone cancer metastatic and experienced Spinal osteoarthritis * :
|Spinal osteoarthritis||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||109.09%||0.00% |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Breast cancer (14 people, 100.00%)
- Metastases to bone (14 people, 100.00%)
- Osteomyelitis (4 people, 28.57%)
Most common drugs used by these people * :
- Aredia (14 people, 100.00%)
- Selenium (14 people, 100.00%)
- Vitamin e (14 people, 100.00%)
- Nasonex (14 people, 100.00%)
- Zometa (14 people, 100.00%)
- Celebrex (14 people, 100.00%)
- Femara (14 people, 100.00%)
- Synthroid (14 people, 100.00%)
- Wellbutrin (13 people, 92.86%)
- Lexapro (13 people, 92.86%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
Get connected! Join a mobile support group:
- group for people who have Spinal Osteoarthritis and Bone cancer metastatic
- group for people who have Bone cancer metastatic
- group for people who have Spinal Osteoarthritis
Common treatments for Bone Cancer Metastatic and their efficacy:
Could your drug cause it?
Comments from related studies:
From this study (2 years ago):
K S Prakash on Apr, 6, 2011:
I used Lopid 300 mg once a day for about 3 to 3.5 months. My blood sugar levels rose...
I stopped Lopid.
Lopid also caused pain in the lower ribs, just above the stomach apart from muscle weakness.
I stopped the drug and awaiting for improvement.
Fresno on Dec, 9, 2012:
Over the past year, I have lost substantial muscle tone. Strength remains ok but significant change is hardness of muscles though my diet and workout routine remain the same. I stopped finasteride and continue to loss muscle tone. Have had blood work and other tests all negative. Any suggestions
william mcniff on Nov, 20, 2012:
No one lost muscle tissue/weight during or after the BMT????Really??? I lost 75lbs during and after my BMT. 205 to 130lbs. I have no muscle mass at all.
It has been over 4 years since my transplant and I still cannot rebuild the lost muscle. This is with
testosterone shots weight training BCAA Whey protein
creatine etc etc etc.
I find it hard to believe muscle wasting did not occur with other patients.
From this study (2 years ago):
diagnosed with mBC in the bones. Fairly advanced, working to manage pain.
nl_adams on Jul, 3, 2012:
Does xeloda aggravate shingles and if so for how long?
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Bone cancer metastatic, Spinal osteoarthritis
More reviews for: Bone cancer metastatic, Spinal osteoarthritis
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.